NASDAQ:CPRX

Catalyst Pharmaceuticals Stock Predictions

Healthcare > Biotechnology

Invest in CPRX

$20.75

-0.200 (-0.95%)

At Close: Jul 08, 2025

Currently predicting for Thu, 10 Jul 2025

Trading levels for CPRX

Full Access. No Commitment. 14 Days Free!

Long & Short-Term Golden Star Lists

AI Stock Analysis Powered by GPT-4o*

Top 5 Candidates on Every List

Premium Lists

Ad-FREE Browsing

Advanced Stock Screener

GET STARTED!

Already have an account? Sign In Here

Fibonacci Support & Resistance Levels

Level	Price
R3	21.50	3.63%
R2	21.26	2.47%
R1	21.11	1.75%
Price	20.75
S1	20.63	-0.565%
S2	20.48	-1.28%
S3	20.24	-2.44%

Accumulated Volume Support & Resistance Levels

Level	Price
R3	24.29	17.06%
R2	22.76	9.69%
R1	21.45	3.37%
Price	20.75
S1	0	-
S2	0	-
S3	0	-

CPRX Predictions History

4 weeks ago
jda999612 predicted that CPRX for Jun. 11th is going

Rank:

5 months ago
PredictionBot.Kathy predicted that CPRX for Jan. 21st is going $22.38 (-1.74%)

5 months ago
PredictionBot.Warren predicted that CPRX for Jan. 21st is going $22.53 (-1.09%)

5 months ago
stanleigh22.413688 predicted that CPRX for Jan. 21st is going

Rank:

1 year ago
PredictionBot.Kathy predicted that CPRX for 2024-05-21 is going $16.69 (0.94%)

1 year ago
PredictionBot.Warren predicted that CPRX for 2024-05-21 is going $16.77 (1.47%)

1 year ago
thedean2010 predicted that CPRX for 2024-05-21 is going

1 year ago
PredictionBot.Kathy predicted that CPRX for 2024-03-19 is going $16.34 (-0.30%)

1 year ago
PredictionBot.Warren predicted that CPRX for 2024-03-19 is going $16.24 (-0.90%)

1 year ago
RKP predicted that CPRX for 2024-03-19 is going $16.50 (2.61%)

ABOUT CATALYST PHARMACEUTICALS

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RYTM $62.29	4.58%	Jun 25
OMCL $28.74	3.20%	Jun 25
NOV $12.25	10.29%	Jun 04
G GTM $9.57	6.06%	Jun 02
UAA $5.84	19.86%	May 09

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by